University of Ottawa Heart Institute

Laura Chow, MD, Cancer Immunotherapy Trailblazer, Joins Summit as Senior Vice President of Clinical Development

Retrieved on: 
Thursday, November 2, 2023
Research, Clinical Trials, Biotechnology, Health, Pharmaceutical, General Health, Other Science, Science, Oncology, Knowledge, Dell Medical School, University of Washington School of Medicine, SMMT, University of Colorado School of Medicine, Associate, Therapy, University, Lung cancer, Head, MD, University of Texas at Austin, Drug, University of Ottawa Heart Institute, Thyroid, Summit, Drug development, Senior, Quality of life, Lung, Disease, JAMA Otolaryngology–Head & Neck Surgery, Immunotherapy, Patient, Moses Austin, Pharmaceutical industry

Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that Laura Chow, MD, has joined Summit Therapeutics as Senior Vice President of Clinical Development.

Key Points: 
  • Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that Laura Chow, MD, has joined Summit Therapeutics as Senior Vice President of Clinical Development.
  • We are very excited to welcome Laura to our team.”
    Dr. Chow remains in active clinical practice as a medical oncologist specialized in lung and head and neck cancers.
  • She joins Summit from Fate Therapeutics, where she was the Vice President of Clinical Development in Solid Tumors.
  • Chow’s experience being on the ground floor of cancer immunotherapy is unmatched,” added Dr. Allen S. Yang, Chief Medical Officer at Summit.

Defeat Duchenne Canada and Parent Project Muscular Dystrophy Award $300,000 (USD) Clinical Fellowship in Duchenne Endocrinology and Bone Fragility

Retrieved on: 
Friday, November 3, 2023
Fertility, Steroid, Children's Hospital of Eastern Ontario, CHEO, Research, APRN, Louisiana Family Forum, Canada Research Chair, Bone, Endocrinology, Organization, Chronic kidney disease-mineral and bone disorder, University of Ottawa Heart Institute, Adrenal insufficiency, Vamorolone, Prednisone, PPMD, Male, Growth, Gender identity, Muscle weakness, University of Ottawa, Risk, Consortium, Duchenne muscular dystrophy, Partnership, DRS, University, Osteoporosis, Weakness, USD, Puberty, Education, DMD, Fracture, Muscular dystrophy, Hospital, Calvarial doughnut lesions-bone fragility syndrome, Human, Nursing, Dietary supplement, Medical device, Pediatrics, Duchenne

WASHINGTON and OTTAWA, ON, Nov. 3, 2023 /PRNewswire/ -- Parent Project Muscular Dystrophy (PPMD), a US nonprofit organization leading the fight to end Duchenne muscular dystrophy (Duchenne), and Defeat Duchenne Canada, Canada's leading charity fighting to defeat Duchenne, today announced a collaborative research award of $300,000 (USD) in support of two Clinical Fellowships in Duchenne Endocrinology and Bone Fragility. The three-year award will sponsor the extended fellowship of Dr. Kim Phung, as well as new fellow Dr. Rana Halloun, under the guidance of Dr. Leanne Ward, Professor of Pediatrics and Research Chair in Pediatric Bone Disorders at the University of Ottawa.

Key Points: 
  • Duchenne is the most common muscular dystrophy in children, affecting approximately one in 5,000 live male births.
  • Duchenne is caused by a change in the dystrophin gene that leads to progressive muscle weakness.
  • In 2021, Dr. Phung was awarded a two-year fellowship in pediatric endocrine and bone diseases at the University of Ottawa, with specific focus on endocrine and bone complications of Duchenne.
  • Ward and Phung will delve into the latest developments and crucial topics related to bone health, growth, puberty, and adrenal insufficiency for Duchenne muscular dystrophy.

Canadian Nurses Foundation Announces Annual Fundraiser to Provide New Mental Health Supports and Grow Nursing Scholarship Program

Retrieved on: 
Wednesday, October 11, 2023
Shift, Night Shift, CNF, Mental Health Commission of Canada, Nursing, Canadian Nurses Association, L'Oréal, Lighting, American Nurses Foundation, Mental health, Ottawa Hospital Research Institute, The Ottawa Hospital, Véronique, University of Ottawa Heart Institute, Night

OTTAWA, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Canadian Nurses Foundation (CNF), a leading national charity that invests in nurses, nursing students and nursing education, will host its annual fundraiser, The Night Shift: Lighting Up the Night for Nurses on November 2, 2023 at Ottawa’s National Arts Centre. Funds raised will go towards the charity’s growing mental health programs, as well as its scholarship program which offers over 100 scholarships and bursaries to nursing students across the country each year.

Key Points: 
  • Funds raised will go towards the charity’s growing mental health programs, as well as its scholarship program which offers over 100 scholarships and bursaries to nursing students across the country each year.
  • “Canadian nurses have faced immense trials and challenges over the past few years that have negatively affected their psychological well-being, which also impacts the health outcomes of Canadians and our entire health care system,” said Rob Gottschalk, CEO, Canadian Nurses Foundation.
  • Most recently, CNF has partnered with the Mental Health Commission of Canada to fund programming and training to help build a well-resourced nursing community with a focus on mental health.
  • To purchase tickets for this can’t-miss event, visit cnfnightshift.ca and follow us on Facebook @cnf.fiic, Instagram @canadiannursesfoundation and X (Twitter) @theCNF using #CNFnightshift

Quit For Good Recommends WHO Modernize Their Tobacco Control Strategy

Retrieved on: 
Monday, October 9, 2023
Health, Smoking, HTP, Republic, Heart, University, University of Ottawa Heart Institute, World Health Organization, Disease, WHO, Nicotine, Speech, Smoker, Policy, Heated tobacco product, Research, FCTC, Science, International Association, Tobacco, UN, Conference, For Good, Public health, Medical device

Dr. Fernando Fernandez Bueno, a Spanish physician, agreed with Dr. Mata: "The debate on tobacco control must be based on scientific arguments and clinical data, moving away from mere opinions and emotional responses.

Key Points: 
  • Dr. Fernando Fernandez Bueno, a Spanish physician, agreed with Dr. Mata: "The debate on tobacco control must be based on scientific arguments and clinical data, moving away from mere opinions and emotional responses.
  • This is the only way to make progress in the fight against tobacco."
  • When we lose the trust of the public, it affects us on a far broader range of issues than just tobacco and nicotine."
  • Dr. Mata highlighted that the FCTC's tobacco control strategies are failing as the number of smokers globally is not decreasing.

Manatt Expands National Cannabis Practice With New York State’s Top Regulator

Retrieved on: 
Tuesday, October 3, 2023
Cannabis, Consulting, Natural Resources, Professional Services, Legal, Consumer protection, Bernabe, Intellectual property, LLP, New York Office of Cannabis Management, Executive, University, Senate, Therapy, Assembly, OCM, Executive Chamber of David Paterson, Oklahoma State Department of Health, Policy, Health equity, Cannabinoid, Privacy, Partner (business rank), University of Ottawa Heart Institute, LL.B, Government, Land use, New York Cannabis Regulation and Taxation Act, United States Department of State, Tom, Computer security, Health care, Map, Economic development, CBD, McGill University, Health, Manatt, Phelps & Phillips, Drug

Manatt, Phelps & Phillips, LLP, a multidisciplinary, integrated professional services firm, today announced the addition of Partner Axel Bernabe to the Firm’s New York office.

Key Points: 
  • Manatt, Phelps & Phillips, LLP, a multidisciplinary, integrated professional services firm, today announced the addition of Partner Axel Bernabe to the Firm’s New York office.
  • At Manatt, Bernabe will tap into his experience—which also includes serving as Chief Health Counsel to Governor Andrew Cuomo for six years, where he led legal and policy developments in the State’s health portfolio—to provide consulting and legal counsel for entities looking to understand cannabis markets and implement cannabis programs at the national and international levels.
  • “Axel’s background working across the health care, cannabis and antitrust sectors throughout his career uniquely positions him to guide clients throughout the country across the sophisticated and highly regulated cannabis markets,” said Donna L. Wilson , Manatt’s CEO and Managing Partner.
  • This work will span the adult-use market, practitioners in the medical cannabis space, the CBD and other cannabinoids market, as well as cannabis-adjacent product and service providers.

Rady Children's Hospital Appoints Adel Younoszai, MD, as Rady Children's Hospital Co-Director of the Heart Institute, and Division Chief of Cardiology, Department of Pediatrics, UC San Diego

Retrieved on: 
Tuesday, October 3, 2023
University of California, San Diego, Ventricular septal defect, University, College of Medicine, Harvard University, Health care, University of Ottawa Heart Institute, Rady Children's Hospital, UCSD, Research, Annals of Pediatric Cardiology, Harvard T.H. Chan School of Public Health, Public health, University of Colorado School of Medicine, UC, MD, Patient, Division, SAN, Child, Neuroscience, Hospital, Pediatric nursing, Dean (education), Nursing, Pediatrics, Cardiology, Echocardiography

Dr. Younoszai will spearhead the evolution of the cardiology department by embracing the technological advancements to empower providers to deliver faster more effective care and improve outcomes.

Key Points: 
  • Dr. Younoszai will spearhead the evolution of the cardiology department by embracing the technological advancements to empower providers to deliver faster more effective care and improve outcomes.
  • "Dr. Younoszai's accomplishments in clinical care, research and in leadership roles are truly impressive."
  • "His accomplishments in clinical care, research and in leadership roles are truly impressive and we're so fortunate to have him join Rady Children's and UC San Diego."
  • "He will be a great Cardiology Chief for our institution, and he joins us at the right time.

EQB announces appointment of Chief Risk Officer

Retrieved on: 
Monday, October 2, 2023
BMO, Science, University, Bank of Montreal, Engineering, Schulich School of Business, Toronto, Business, Risk management, Dean, MBA, University of Ottawa Heart Institute, Enterprise risk management, Chemical substance, McMaster University, Faculty, TSX, Bank, Equitable Bank, Chemical engineering, EQB, Management

TORONTO, Oct. 2, 2023 /PRNewswire/ - EQB Inc. (TSX: EQB) (TSX: EQB.PR.C) and its wholly owned subsidiary Equitable Bank (the "Bank"), are pleased to announce that Marlene Lenarduzzi will be joining the Bank as its Chief Risk Officer on October 10, 2023.

Key Points: 
  • TORONTO, Oct. 2, 2023 /PRNewswire/ - EQB Inc. (TSX: EQB) (TSX: EQB.PR.C) and its wholly owned subsidiary Equitable Bank (the "Bank"), are pleased to announce that Marlene Lenarduzzi will be joining the Bank as its Chief Risk Officer on October 10, 2023.
  • She comes to the Bank following more than 25 years of experience in risk management and banking with depth in strategy development, regulatory relationships, risk quantification, operations, and execution.
  • Prior to joining EQB, Ms. Lenarduzzi was Head, Counterparty Credit Risk Management and Market Risk Strategic Initiatives at BMO Financial Group.
  • Ms. Lenarduzzi will lead the Bank's risk department and will be the head of its Enterprise Risk Management function with responsibility for credit, operational and enterprise risk.

Heart Checkups Advised for Kids Who Play Sports

Retrieved on: 
Friday, July 28, 2023
Hospitals, Health, Cardiology, Exercise, Heart, Cardiac stress test, Bachelor of Medicine, Bachelor of Surgery, Posture, Cardiac arrest, Arrest, American Heart Association, CHLA, University of Ottawa Heart Institute, Weakness, ECG, Myocarditis, Artery, Inflammation, Virus, Facial muscles, Athlete, Ice, Hypertrophic cardiomyopathy, Congenital heart defect, Risk, Master of Science, Children's Hospital Los Angeles, Sport, Diagnosis, FRCPC, Transthoracic echocardiogram, Death, Dietary supplement, Medical device, Medical imaging

Pre-participation heart screenings are advised for athletes ages 12 and above.

Key Points: 
  • Pre-participation heart screenings are advised for athletes ages 12 and above.
  • Heart defects don’t prohibit kids from playing sports.
  • An example of an acquired abnormality is myocarditis, an inflammation of the heart that can develop from a viral illness.
  • Dr. Kantor and his colleagues often see kids who are referred to the Heart Institute after a checkup by their pediatrician flags a heart issue that could pose a risk during intense exertion.

Dr. Doria A. Scortichini MD, FACC Joins Auburn Heart Institute

Retrieved on: 
Wednesday, July 19, 2023
Workforce, Auburn Hospital, Jacobi Medical Center, Auburn Community Hospital, Primary care, ACH, Multimedia, Cardiology, Finger Lakes, Drug, University of Ottawa Heart Institute, National Association Medical Staff Services, Medical director, Patient, Investment, The Hospital, Physician, MD, Internal medicine, Tertiary referral hospital, Hospital, Union University, Montreal Heart Institute, Lake, Medical device

AUBURN, N.Y., July 19, 2023 /PRNewswire/ -- Dr. Doria Scortichini, MD FACC joins the growing Auburn Heart Institute that is affiliated with Auburn Community Hospital.  Dr. Scortichini is a cardiology specialist in Geneva, New York and has over 40 years of experience in cardiovascular diseases.  Dr. Scortichini graduated from Albany Medical College of Union University and completed her residency and cardiology fellowship at Bronx Municipal Hospital and Albert Einstein College of Medicine Hospital followed by a fellowship in interventional cardiology at the Montreal Heart Institute. Dr. Scortichini is board certified in Internal Medicine and Cardiovascular Diseases.

Key Points: 
  • AUBURN, N.Y., July 19, 2023 /PRNewswire/ -- Dr. Doria Scortichini, MD FACC joins the growing Auburn Heart Institute that is affiliated with Auburn Community Hospital.
  • "We are thrilled to have someone of Dr. Scortichini' s experience join the Auburn Heart Institute and Auburn Community Hospital.
  • "I am excited to join the team at the Auburn Heart Institute, and to be part of Auburn Hospital and this community.
  • Patients can begin scheduling appointments immediately to be seen by Dr. Scortichini at the Auburn Heart Institute 3rd Floor Auburn Community Hospital  - Please call:  315-567-0540 for appointments.

Dr. Joseph Forbess Joins Nicklaus Children's as Chief of Cardiovascular Surgery

Retrieved on: 
Wednesday, June 28, 2023
Duke University Hospital, Boston Children's Hospital, Ventricular septal defect, University, CV, University of Maryland Medical System, Isenberg School of Management, American Heart Association, Society of Thoracic Surgeons, American College of Cardiology, English, University of Texas at Austin, Research, American College of Surgeons, University of Maryland Medical Center, U.S. News & World Report, University of Maryland School of Medicine, Harvard Medical School, Cardiothoracic surgery, University of Ottawa Heart Institute, Maryland School, Hospital, Patient, NCPS, Child, Pediatrics, Society, General surgery, Growth, American College, Trauma, Elective surgery, News, Nursing, Dentistry, Nicklaus Children's Hospital, Cardiology

MIAMI, June 28, 2023 /PRNewswire/ -- Renowned pediatric cardiovascular surgeon Dr. Joseph M. Forbess has joined Nicklaus Children's Pediatric Specialists (NCPS) as chief of the Section of Cardiovascular (CV) Surgery, and assumes a leadership position within the Nicklaus Children's Heart Institute.

Key Points: 
  • MIAMI, June 28, 2023 /PRNewswire/ -- Renowned pediatric cardiovascular surgeon Dr. Joseph M. Forbess has joined Nicklaus Children's Pediatric Specialists (NCPS) as chief of the Section of Cardiovascular (CV) Surgery, and assumes a leadership position within the Nicklaus Children's Heart Institute.
  • Dr. Forbess will lead the Nicklaus Children's Heart Institute in collaboration with Dr. Lourdes Prieto, chief of the Section of Cardiology, with support from Dr. Burke.
  • Nicklaus Children's is ranked among the nation's best hospitals for pediatric cardiology and heart surgery by U.S. News & World Report.
  • Dr. Burke has been an instrumental leader in Nicklaus Children's Cardiovascular Surgery program, having helped the team and the program attain national notoriety.